Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study. These ...

Both MDR-TB and XDR-TB pose an enormous health burden. While treatment cost is high, being 100-times more expensive than the best first-line regimen, treatment success rates for these diseases are ...

Some 34 medical specialists and medical doctors from district hospitals in the country attended a two-day training on shorter regimen of multi-drug-resistant tuberculosis (MDR-TB) treatment in Paro.

New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that ...

The results of a large, international systematic review published in the journal PLOS Medicine show that tuberculosis treatment is successful in children with multidrug-resistant tuberculosis (MDR-TB) ...

This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.

Despite strong national programmes, late diagnosis, treatment gaps, private-sector fragmentation, and poor adherence remain ...

Expert Rev Clin Pharmacol. 2009;2(4):405-421. Ethambutol (EMB) and pyrazinamide (PZA) in Category A should be included in the regimen for treatment of MDR-TB, if they are likely to be effective from ...